Read + Share
Hao Q, Aertgeerts B, Guyatt G, Bekkering GE, et al. PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a
clinical practice guideline with risk-stratified recommendations. BMJ 2022;377:e069066.
PMID: 35508320
|
 |
|
Hao Q, Aertgeerts B, Guyatt G, Bekkering GE, et al. PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a
clinical practice guideline with risk-stratified recommendations. BMJ 2022;377:e069066.
PMID: 35508320
|
|
|
|